According to Tempest Therapeutics's latest financial reports the company's current earnings (TTM) are -C$41.05 M. In 2023 the company made an earning of -C$38.04 M an increase over its 2022 earnings that were of -C$46.25 M.The earnings displayed on this page is the company's Pretax Income.